Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function - PubMed
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
An official website of the United States government
Here's how you know
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Log in
Show account info
Close
Account
Logged in as:
username
Dashboard
Publications
Account settings
Log out
Access keys
NCBI Homepage
MyNCBI Homepage
Main Content
Main Navigation
Search:
Search
Advanced
Clipboard
User Guide
Save
Email
Send to
Clipboard
My Bibliography
Collections
Citation manager
Display options
Display options
Format
Abstract
PubMed
PMID
Save citation to file
Format:
Summary (text)
PubMed
PMID
Abstract (text)
CSV
Create file
Cancel
Email citation
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
To:
Subject:
Body:
Format:
Summary
Summary (text)
Abstract
Abstract (text)
MeSH and other data
Send email
Cancel
Add to Collections
Create a new collection
Add to an existing collection
Name your collection:
Name must be less than 100 characters
Choose a collection:
Unable to load your collection due to an error
Please try again
Add
Cancel
Add to My Bibliography
My Bibliography
Unable to load your delegates due to an error
Please try again
Add
Cancel
Your saved search
Name of saved search:
Search terms:
Test search terms
Would you like email updates of new search results?
Saved Search Alert Radio Buttons
Yes
No
Email:
(change)
Frequency:
Monthly
Weekly
Daily
Which day?
The first Sunday
The first Monday
The first Tuesday
The first Wednesday
The first Thursday
The first Friday
The first Saturday
The first day
The first weekday
Which day?
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Report format:
Summary
Summary (text)
Abstract
Abstract (text)
PubMed
Send at most:
1 item
5 items
10 items
20 items
50 items
100 items
200 items
Send even when there aren't any new results
Optional text in email:
Save
Cancel
Create a file for external citation management software
Create file
Cancel
Your RSS Feed
Name of RSS Feed:
Number of items displayed:
5
10
15
20
50
100
Create RSS
Cancel
RSS Link
Copy
Full text links
Elsevier Science
Full text links
Actions
Cite
Collections
Add to Collections
Create a new collection
Add to an existing collection
Name your collection:
Name must be less than 100 characters
Choose a collection:
Unable to load your collection due to an error
Please try again
Add
Cancel
Permalink
Permalink
Copy
Display options
Display options
Format
AbstractPubMedPMID
Page navigation
Title & authors
Abstract
Publication types
MeSH terms
Substances
LinkOut - more resources
Title & authors
Abstract
Publication types
MeSH terms
Substances
LinkOut - more resources
Thromb Res
Actions
Search in PubMed
Search in NLM Catalog
Add to Search
. 2000 Aug 15;99(4):343-52.
doi: 10.1016/s0049-3848(00)00257-7.
Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function
V van Wyk 
1
, L Leblond, P D Winocour, D V Devine, M I Gyongyossy-Issa
Affiliations
Expand
Affiliation
1 Department of Haematology and Cell Biology, University of the Orange Free State, Bloemfontein, South Africa. gnhmvvw@med.uovs.ac.za
PMID:
10963785
DOI:
10.1016/s0049-3848(00)00257-7
Item in Clipboard
Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function
V van Wyk et al.
Thromb Res.
2000.
Show details
Display options
Display options
Format
Abstract
PubMed
PMID
Thromb Res
Actions
Search in PubMed
Search in NLM Catalog
Add to Search
. 2000 Aug 15;99(4):343-52.
doi: 10.1016/s0049-3848(00)00257-7.
Authors
V van Wyk 
1
, L Leblond, P D Winocour, D V Devine, M I Gyongyossy-Issa
Affiliation
1 Department of Haematology and Cell Biology, University of the Orange Free State, Bloemfontein, South Africa. gnhmvvw@med.uovs.ac.za
PMID:
10963785
DOI:
10.1016/s0049-3848(00)00257-7
Item in Clipboard
Full text links
Cite
Display options
Display options
Format
AbstractPubMedPMID
Abstract
We investigated the effect on in vitro platelet function of hirutonin, a modified hirutonin with an RGD-like motif, a pseudo-RGDS peptide and a linear RGDS peptide. Inhibition of expression of surface fibrinogen on ADP-activated platelets with 40 microM of the peptide was as follows: hirutonin 10+/-3%, modified chimeric peptide 26+/-5%, pseudo-RGDS 66+/-11% and linear RGDS 93+/-13%. Both hirutonin and the chimeric peptide significantly inhibited ADP-induced platelet activation as detected by CD62 expression. Unlike the RGDS and pseudo-RGDS controls, neither the chimeric peptide nor the parent hirutonin inhibited ADP-induced platelet aggregation even at 140 microM. The chimeric hirutonin peptide reduced ATP release from ADP-stimulated platelets by 40+/-4%. This inhibition was stronger than that caused by hirutonin (23+/-13%), but less than the RGDS (90+/-2%) and pseudo RGDS-peptides (59+/-11%). Primary platelet haemostasis was slightly but not significantly affected by the peptide at 40 and 80 microM. However, shear-induced platelet adhesion to vWF and especially subsequent aggregate formation was interrupted after the addition of the chimeric peptide. Similar results were obtained with hirutonin. This inhibition was not as marked as with the RGDS- and pseudo-RGDS peptides. Both the parent hirutonin and the chimeric peptide caused prolongation of the clinical coagulation assays aPTT and TT. In conclusion, the chimeric hirutonin peptide with introduction of the RGD motif retained its anticoagulant effect but had little formal disintegrin activity. Instead, it appeared to have novel anti-platelet effects that may be of therapeutic use.
PubMed Disclaimer
Publication types
Research Support, Non-U.S. Gov't
Actions
Search in PubMed
Search in MeSH
Add to Search
MeSH terms
Adenosine Triphosphate / metabolism
Actions
Search in PubMed
Search in MeSH
Add to Search
Amino Acid Motifs
Actions
Search in PubMed
Search in MeSH
Add to Search
Amino Acid Sequence
Actions
Search in PubMed
Search in MeSH
Add to Search
Blood Coagulation Tests
Actions
Search in PubMed
Search in MeSH
Add to Search
Fibrinogen / antagonists & inhibitors
Actions
Search in PubMed
Search in MeSH
Add to Search
Fibrinogen / metabolism
Actions
Search in PubMed
Search in MeSH
Add to Search
Fibrinolytic Agents / chemistry
Actions
Search in PubMed
Search in MeSH
Add to Search
Fibrinolytic Agents / pharmacology
Actions
Search in PubMed
Search in MeSH
Add to Search
Hemostasis / drug effects
Actions
Search in PubMed
Search in MeSH
Add to Search
Hirudins / analogs & derivatives*
Actions
Search in PubMed
Search in MeSH
Add to Search
Hirudins / antagonists & inhibitors
Actions
Search in PubMed
Search in MeSH
Add to Search
Hirudins / chemistry
Actions
Search in PubMed
Search in MeSH
Add to Search
Hirudins / pharmacology*
Actions
Search in PubMed
Search in MeSH
Add to Search
Humans
Actions
Search in PubMed
Search in MeSH
Add to Search
Oligopeptides / chemistry*
Actions
Search in PubMed
Search in MeSH
Add to Search
Peptides / chemical synthesis
Actions
Search in PubMed
Search in MeSH
Add to Search
Peptides / chemistry
Actions
Search in PubMed
Search in MeSH
Add to Search
Peptides / pharmacology
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Activation / drug effects
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Adhesiveness / drug effects
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Aggregation / drug effects
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Aggregation Inhibitors / chemistry
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Aggregation Inhibitors / pharmacology*
Actions
Search in PubMed
Search in MeSH
Add to Search
Protein Binding / drug effects
Actions
Search in PubMed
Search in MeSH
Add to Search
Protein Engineering
Actions
Search in PubMed
Search in MeSH
Add to Search
von Willebrand Factor / metabolism
Actions
Search in PubMed
Search in MeSH
Add to Search
Substances
Fibrinolytic Agents
Actions
Search in PubMed
Search in MeSH
Add to Search
Hirudins
Actions
Search in PubMed
Search in MeSH
Add to Search
Oligopeptides
Actions
Search in PubMed
Search in MeSH
Add to Search
Peptides
Actions
Search in PubMed
Search in MeSH
Add to Search
Platelet Aggregation Inhibitors
Actions
Search in PubMed
Search in MeSH
Add to Search
von Willebrand Factor
Actions
Search in PubMed
Search in MeSH
Add to Search
Adenosine Triphosphate
Actions
Search in PubMed
Search in MeSH
Add to Search
Fibrinogen
Actions
Search in PubMed
Search in MeSH
Add to Search
arginyl-glycyl-aspartyl-serine
Actions
Search in PubMed
Search in MeSH
Add to Search
LinkOut - more resources
Full Text Sources
Elsevier Science
Medical
MedlinePlus Health Information
Miscellaneous
NCI CPTAC Assay Portal
Full text links
[x]
Elsevier Science
[x]
Cite
Copy
Download .nbib
.nbib
Format:
AMA
APA
MLA
NLM
Send To
Clipboard
Email
Save
My Bibliography
Collections
Citation Manager
[x]
NCBI Literature Resources
MeSH
PMC
Bookshelf
Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Follow NCBI
Twitter
Facebook
LinkedIn
GitHub
Connect with NLM
Twitter
SM-Facebook
SM-Youtube
National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894
Web Policies
FOIA
HHS Vulnerability Disclosure
Help
Accessibility
Careers
NLM
NIH
HHS
USA.gov